Iovance Biotherapeutics, Inc. (IOVA) stock analysis
IOVA · Iovance Biotherapeutics, Inc.
Latest recorded price: USD 7.55
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: free cash flow margin -127.6%, ROIC -98.6%. The model flags 2 risk signals for this company (1 high severity).
Similar companies in Healthcare
- Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
- Korsana Biosciences, Inc. (KRSA)
- Krystal Biotech, Inc. - Common Stock (KRYS)
- Kymera Therapeutics, Inc. - Common Stock (KYMR)
- Ligand Pharmaceuticals Incorporated - Common Stock (LGND)
- Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL)
- MeiraGTx Holdings plc (MGTX)
- Mirum Pharmaceuticals, Inc. - common stock (MIRM)